22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific Review

Stock Information for 22nd Century Group Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About 22nd Century Group Inc

22nd Century Group (Nasdaq: XXII) Ignites Major VLN® Retail Expansion in Metro New York and Northern New Jersey Under Pinnacle Brand 
22nd Century Group Reports First Quarter 2026 Financial Results
22nd Century Group to Announce First Quarter 2026 Results on May 7, 2026
22nd Century Group Shares 2026 Vision for VLN® Product Growth and Tobacco Harm Reduction Leadership
22nd Century Group Expands Reduced Nicotine Platform Through New Testing Services Agreement with North Carolina State University
22nd Century Advances Reduced Nicotine Product to Target Approximately Half of the ~$82 Billion U.S. Cigarette Market with 100mm VLN® Product Initiative
22nd Century Group Reports Fourth Quarter and Full Year 2025 Financial Results
22nd Century Group to Announce Fourth Quarter and Full Year 2025 Results on March 26, 2026

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.